| 2024-08-22 |
详情>>
内部人交易：
Starling William N JR等共交易8笔
|
| 2024-08-13 |
详情>>
股本变动：
变动后总股本27284.26万股
|
| 2024-08-13 |
详情>>
业绩披露：
2024年中报每股收益-0.18美元,归母净利润-4824.6万美元,同比去年增长-12.51%
|
| 2024-08-13 |
财报披露：
美东时间 2024-08-13 盘后发布财报
|
| 2024-07-05 |
股东大会：
将于2024-08-07召开股东大会
会议内容 ▼▲
- 1.Merger Proposal. To approve and adopt the Agreement and Plan of Merger, dated as of June 6, 2024 (which, as it may be amended from time to time, we refer to as the “merger agreement”), by and among KARL STORZ Endoscopy-America, Inc., a California corporation (“Parent”), and Karl Storz California Inc., a California corporation (“Merger Sub”), pursuant to which Asensus would be acquired by way of a merger with and into Merger Sub with Asensus surviving the merger and becoming a wholly-owned subsidiary of Parent, which we refer to as the “merger.”
2.Merger-Related Compensation Proposal. To approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger.
3.Adjournment Proposal. To approve one or more adjournments of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the merger proposal at the time of the special meeting.
|
| 2024-06-11 |
复牌提示：
2024-06-07 08:34:22 停牌，复牌日期 2024-06-07 09:00:00
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.08美元,归母净利润-2249.7万美元,同比去年增长-1.26%
|
| 2024-03-21 |
详情>>
业绩披露：
2023年年报每股收益-0.31美元,归母净利润-7843.3万美元,同比去年增长-3.8%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.25美元,归母净利润-6119.8万美元,同比去年增长-6.12%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.18美元,归母净利润-4288万美元,同比去年增长-10.67%
|
| 2023-05-11 |
详情>>
业绩披露：
2023年一季报每股收益-0.09美元,归母净利润-2221.8万美元,同比去年增长-16.15%
|
| 2023-04-27 |
股东大会：
将于2023-06-06召开股东大会
会议内容 ▼▲
- 1.Election of Directors. The election of the seven director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.Say on Pay. An advisory vote to approve the compensation paid to the Company’s named executive officers for 2022.
3.Frequency of Say on Pay Vote. An advisory vote regarding the frequency of submission of future say on pay votes to the stockholders for approval.
4.Amendment of the Incentive Compensation Plan. A vote to amend the Asensus Surgical, Inc. Amended and Restated Incentive Compensation Plan, as amended (the “Plan”), to approve an increase in the number of shares reserved for issuance under the Plan by 22,000,000 shares.
5.Ratification of Appointment of Independent Accounting Firm. Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
6.Other Matters. The transaction of such other business as may lawfully come before the Annual Meeting or at any adjournment or postponement.
|
| 2023-03-02 |
详情>>
业绩披露：
2022年年报每股收益-0.32美元,归母净利润-7556.1万美元,同比去年增长-20.97%
|
| 2022-11-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.24美元,归母净利润-5767.1万美元,同比去年增长-23.81%
|
| 2022-08-08 |
详情>>
业绩披露：
2022年中报每股收益-0.16美元,归母净利润-3874.7万美元,同比去年增长-26.99%
|
| 2022-05-04 |
详情>>
业绩披露：
2022年一季报每股收益-0.08美元,归母净利润-1912.8万美元,同比去年增长-10.31%
|
| 2022-04-25 |
股东大会：
将于2022-06-14召开股东大会
会议内容 ▼▲
- 1.The election of the seven director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.An advisory vote to approve the compensation paid to the Company’s named executive officers for 2021.
3.Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
4.The transaction of such other business as may lawfully come before the Annual Meeting or at any adjournment or postponement.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-22 |
股东大会：
将于2021-06-03召开股东大会
会议内容 ▼▲
- 1.The election of the seven director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.A vote to amend and restate the Asensus Surgical, Inc. Amended and Restated Incentive Compensation Plan (the “Plan”), to approve an increase in the number of shares reserved for issuance under the Plan by 22,000,000.
3.An advisory vote to approve the compensation paid to the Company’s named executive officers for 2020.
4.An advisory vote regarding the frequency of submission of future say on pay votes to the stockholders.
5.Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
6.The transaction of such other business as may lawfully come before the Annual Meeting or at any adjournment or postponement.
|
| 2020-04-27 |
股东大会：
将于2020-06-08召开股东大会
会议内容 ▼▲
- 1.Election of Directors. The election of the seven director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.Amendment and Restatement of the Incentive Compensation Plan. A vote to amend and restate the TransEnterix, Inc. Amended and Restated Incentive Compensation Plan (the “Plan”), to approve an increase in the number of shares reserved for issuance under the Plan by 6,000,000 shares and to make other changes.
3.Say on Pay. An advisory vote to approve the compensation paid to the Company’s named executive officers for 2019.
4.Ratification of Appointment of Independent Accounting Firm. Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020.
5.Other Matters. The transaction of such other business as may lawfully come before the Annual Meeting or at any adjournment or postponement.
|
| 2019-12-12 |
详情>>
拆分方案：
每13.0000合并分成1.0000股
|
| 2019-10-30 |
股东大会：
将于2019-12-18召开股东大会
会议内容 ▼▲
- 1.To approve the adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation, to effect a reverse stock split at a ratio of not less than one-for-ten and not more than one-for-forty, such ratio and the implementation and timing of such reverse stock split to be determined in the discretion of our Board of Directors, provided that any fractional shares resulting from the reverse stock split shall be automatically rounded up to the next whole share, and to reduce the authorized shares of Common Stock to 500,000,000 shares in the event of a Reverse Stock Split at a ratio of one-for-twenty through one-for-thirty or to 250,000,000 shares in the event of a Reverse Stock Split at a ratio over one-for-thirty.
2.To approve one or more adjournments to the Special Meeting, if necessary or appropriate, to permit further solicitation of proxies if there are not sufficient votes at the time of the Special Meeting cast in favor of Proposal No. 1;
3.To transact such other business as may properly come before the Special Meeting or any adjournment or adjournments thereof.
|
| 2019-03-15 |
股东大会：
将于2019-04-24召开股东大会
会议内容 ▼▲
- 1.Election of Directors. The election of the nine director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.Say on Pay. An advisory vote to approve the compensation paid to the Company’s named executive officers for 2018.
3.Amendment and Restatement of the Incentive Compensation Plan. A vote to amend and restate the TransEnterix, Inc. Amended and Restated Incentive Compensation Plan, as amended (the “Plan”) to approve an increase in the number of shares reserved for issuance under the Plan by 12,000,000 shares and to make other changes.
4.Ratification of Appointment of Independent Accounting Firm. Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.
5.Other Matters. The transaction of such other business as may lawfully come before the Annual Meeting or any adjournments thereof.
|
| 2018-04-13 |
股东大会：
将于2018-05-24召开股东大会
会议内容 ▼▲
- 1.Election of Directors. The election of the nine director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.Say on Pay. An advisory vote to approve the compensation paid to the Company’s named executive officers for 2017.
3.Amendment and Restatement of the Incentive Compensation Plan. A vote to amend and restate the TransEnterix, Inc. Amended and Restated Incentive Compensation Plan, as amended (the “Plan”) to approve an increase in the number of shares reserved for issuance under the Plan by 15,000,000 shares.
4.Ratification of Appointment of Independent Accounting Firm. Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.
5.Other Matters. The transaction of such other business as may lawfully come before the Annual Meeting or any adjournments thereof.
|
| 2017-04-21 |
股东大会：
将于2017-05-25召开股东大会
会议内容 ▼▲
- 1.Election of Directors. The election of the nine director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2.Say on Pay. An advisory vote to approve the compensation paid to the Company’s named executive officers for 2016.
3.Frequency of Say on Pay Vote. An advisory vote regarding the frequency of submission of future say on pay votes to the stockholders for approval.
4.Amendment of the Incentive Compensation Plan. A vote to amend the TransEnterix, Inc. Amended and Restated Incentive Compensation Plan, as amended (the “Plan”) to approve an increase in the number of shares reserved for issuance under the Plan by 7,000,000 shares.
5.Ratification of Appointment of Independent Accounting Firm. Ratification of the appointment of BDO USA LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017.
6.Other Matters. The transaction of such other business as may lawfully come before the Annual Meeting or any adjournments thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-08召开股东大会
会议内容 ▼▲
- 1. Election of Directors. The election of the nine director nominees named in the attached proxy statement to serve as directors until the next annual meeting of stockholders and until their successors are elected and qualified.
2. Say on Pay. An advisory vote to approve the compensation paid to the Company’s named executive officers for 2015.
3. Amendment of the Incentive Compensation Plan. A vote to amend the TransEnterix, Inc. Amended and Restated Incentive Compensation Plan, as amended (the “Plan”) to (1) approve an increase in the number of shares reserved for issuance under the Plan by 7,000,000 shares and (2) to establish maximum equity award limits for initial awards and annual awards to non-employee directors.
4. Ratification of Appointment of Independent Accounting Firm. Ratification of the appointment of BDO USA LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016.
5. Other Matters. The transaction of such other business as may lawfully come before the Annual Meeting or any adjournments thereof.
|